Article ; Online: Estudio de los pacientes con elevación de enzima Creatinfosfokinasa en dos hospitales de tercer nivel de la ciudad de córdoba.
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
2022 Volume 79, Issue 4, Page(s) 327–333
Abstract: Introduction: HyperCKemia is defined as the elevation of creatine phosphokinase (CK) levels greater than 1.5 times the upper limit (CK>285 U/L), being produced by multiple causes, which vary according different populations. The main objective of the ... ...
| Title translation | Creatine phosphokinase enzyme elevation in two third-level hospitals of Córdoba. |
|---|---|
| Abstract | Introduction: HyperCKemia is defined as the elevation of creatine phosphokinase (CK) levels greater than 1.5 times the upper limit (CK>285 U/L), being produced by multiple causes, which vary according different populations. The main objective of the study was to know the frequency of hyperCKemia in two hospitals in Córdoba and its main causes. Methods: Retrospective analytical study in two hospitals in Córdoba, Argentina, where all patients over 18 years of age who presented CK values greater than 285 U/L on at least 2 occasions in a period between 1 and 4 weeks were identified, between the years 2015 and 2017. Results: 254 patients with hyperCKemia were identified, the majority were male (n=181, 71.3%) and their median age was 65 years (interquartile range 25-75%=50-73 years). The main causes of hyperCKemia were ischemic myopathy in 99 (39%) patients and drug-induced myopathies in 45 (17.7%), with statins being the most frequently involved drugs in 31 cases. In only 3.1% of the cases the final diagnosis was not reached. Drug-induced hyperCKemias, when compared to other causes, occurred more frequently in patients with a history of chronic kidney disease (9/45 [20%] vs 18/209 [8.6%], p = 0.025) and in non-smokers (41/45 [91.1%] vs. 157/209 [75.1%], p=0.019). Main conclusion: 254 cases of hyperCKemia were observed, the main causes being of ischemic origin and secondary to drug use, especially statins. |
| MeSH term(s) | Humans ; Male ; Female ; Adolescent ; Adult ; Creatine Kinase ; Retrospective Studies ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Hospitals ; Renal Insufficiency, Chronic |
| Chemical Substances | Creatine Kinase (EC 2.7.3.2) ; Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Language | Spanish |
| Publishing date | 2022-12-21 |
| Publishing country | Argentina |
| Document type | English Abstract ; Journal Article |
| ZDB-ID | 390127-0 |
| ISSN | 1853-0605 ; 0014-6722 ; 0301-7281 |
| ISSN (online) | 1853-0605 |
| ISSN | 0014-6722 ; 0301-7281 |
| DOI | 10.31053/1853.0605.v79.n4.36031 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 2644: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.